Long-Term Results of the Treatment of Patients With Chronic Ischemia of the Lower Limbs in Combination With Ischemic Heart Disease

Aim      To compare long-term outcomes of x-ray endovascular (percutaneous coronary intervention, PCI, and lower limb angioplasty with stent placement, LLA; group 1) and combination treatments (PCI and open LLA surgery; group 2) in patients with chronic lower limb ischemia (CLLI) associated with ischemic heart disease (IHD).

Material and methods  This retrospective study has been conducted in the Vishnevsky National Medical Research Center of Surgery since 2019. The study includes 92 patients with stage 2B CLLI associated with IHD who were managed from January 1, 2017 through December 31, 2020. Long-term outcomes were evaluated in 76 (82.6 %) patients. The endpoint was severe cardiovascular complications (CVC), including death, myocardial infarction, and acute cerebrovascular disease (ACVD).

Results In group 1 during the long-term period, 1 (2.7%) fatal outcome due to pneumonia was observed. In group 2, 4 (10 %) patients died: 1 (2.5 %) patient due to ACVD, 1 (2.5 %) patient due to progression of oncological process, and 2 2 (5 %) patients due to COVID-19. Also, 2 (5.5 %) and 1 (2.5 %) cases of acute coronary syndrome (ACS) were observed in groups 1 and 2, respectively (p=0.61).

Conclusion      In the x-ray endovascular (group1) and the combination (group 2) intervention groups, lethal outcomes due to myocardial infarction were absent. This fact confirms the importance of PCI in patients with CLLI for prevention of possible ACS in the long-term. Both therapeutic tactics in managing CLLI patients with IHD demonstrated high safety and clinical efficacy during the hospital and long-term periods and can be extensively used in routine clinical practice.

1. Amit N. Keswani, Joshua А. Beckman. The Natural History of Intermittent Claudication. Vol. 18, No. 9 September 2019. ENDOVASCULAR TODAY.

2. Olinic D., Spinu M., Olinic M., Homorodean C., Tataru D. A., Liew A. et al. Epidemiology of peripheral artery disease in Europe: VAS educational paper. Int. Angiol. 2018; 37, 327–334. DOI: 10.23736/S0392-9590.18.03996-2

3. Matskeplishvili S., Kontsevaya A. Cardiovascular Health, Disease, and Care in Russia. Circulation. 2021;144:586–588, DOI: 10.1161/CIRCULATIONAHA.121.055239

4. Aboyans V., Ricco J.B., Bartelink M. L., Björck M., Brodmann M., Cohnert T. et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the european society for vascular surgery (ESVS). European Heart Journal. 2017; 39(9), 763–816. DOI:10.1093/eurheartj/ehx095

5. Sigvant B. et al The Risk of Disease Progression in Peripheral Arterial Disease is Higher than Expected: A Meta-Analysis of Mortality and Disease Progression in Peripheral Arterial Disease Eur J Vasc Endovasc Surg. 2016 Mar;51(3):395-403. DOI: 10.1016/j.ejvs.2015.10.022

6. Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., Fowkes, F. G. R. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) 2007. Journal of Vascular Surgery, 45(1), S5–S67. DOI:10.1016/j.jvs.2006.12.037

7. Jones, W. S., Patel, M. R., Dai, D., Vemulapalli, S., Subherwal, S., Stafford, J., & Peterson, E. D. (2013). High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease. American Heart Journal, 165(5), 809–815.e1. DOI:10.1016/j.ahj.2012.12.002

8. Alekyan B.G., Pokrovsky A.V., Karapetyan N.G., Revishvili А.S. A multidisciplinary approach in determining of prevalence of coronary artery disease and treatment strategies in patients with pathology of the aorta and peripheral arteries. Russian Journal of Cardiology. 2019;(8):8-16. [Russian: Алекян Б.Г., Покровский А.В., Карапетян Н.Г., Ревишвили А.Ш. Мультидисциплинарный подход в определении частоты выявления ишемической болезни сердца и стратегии лечения у пациентов с патологией аорты и периферических артерий. Российский кардиологический журнал. 2019; 24 (8): 8–16.] DOI:10.15829/1560-4071-2019-8-8-16

9. Valgimigli M., Bueno, H., Byrne, R. A., Collet, J. P., Costa, F., Jeppsson, A., Levine, G. N. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS // European journal of cardio-thoracic surgery. 2018. – Т. 53. – №. 1. – С. 34-78.

10. Alekyan B.G., Pokrovskiy А.V., Karapetyan N.G. et al. «Comparative characteristics of postoperative outcomes of different treatment strategies of patients with intermittent claudication in combination with coronary arteries disease». Журнал «Кардиология» - в печати.

11. Raghunathan A., Rapp J. H., Littooy F., Santilli S., Krupski W. C., Ward H. B. et al. Postoperative outcomes for patients undergoing elective revascularization for critical limb ischemia and intermittent claudication: a subanalysis of the coronary artery revascularization prophylaxis (CARP) trial. J. of vasc. surg. 2006; 43(6). DOI:10.1016/j.jvs.2005.12.069

12. McFalls E. O., Ward H. B., Moritz T. E., Goldman S., Krupski W. C., Littooy F. et al. Coronary-artery revascularization before elective major vascular surgery. New Eng. J. of Med. 2004; 351(27), 2795–2804. DOI:10.1056/nejmoa041905

13. Landesberg G., Mosseri M. PRO: preoperative coronary revascularization in high-risk patients undergoing vascular surgery. Anesthesia& Analgesia. 2008; 106(3), 759–763. DOI:10.1213/ane.0b013e3181685054

14. Monaco M., Stassano P., Di Tommaso L., Pepino P., Giordano A., Pinna G. B. et al. Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients. J. of the Amer. Col. of Card.. 2009; 54(11), 989–996. DOI:10.1016/j.jacc.2009.05.041

15. Frank L.J. Visseren, Franc¸ois Mach, Yvo M. Smulders, David Carballo, Konstantinos C. Koskinas, Maria Back et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal (2021) 00, 1111. DOI:10.1093/eurheartj/ehab484